Showing results (1-10 of 204) with videos related to
Sort By:
Pageof 21
British Journal of Cancer|March 1, 1994
Stimulation of erythropoiesis by the non-steroidal anti-androgen nilutamide in men with prostate cancer: evidence for an agonistic effect?A Decensi, R Torrisi, V FontanaJournal of Cellular Biochemistry. Supplement|January 1, 1993
Breast cancer chemoprevention: studies with 4-HPR alone and in combination with tamoxifen using circulating growth factors as potential surrogate endpointsA Decensi, F Formelli, R Torrisi, et al.Oncology Reports|May 25, 2011
Fenretinide in breast-cancer chemoprevention (review)A Decensi, F Formelli, R Torrisi, et al.Drugs|July 4, 2001
Chemoprevention of breast cancer with fenretinideR Torrisi, A Decensi, F Formelli, et al.The Prostate|January 1, 1994
Effect of the nonsteroidal antiandrogen nilutamide on adrenal androgen secretionA Decensi, R Torrisi, P Marroni, et al.European Journal of Cancer (Oxford, England : 1990)|August 26, 1998
Socioeconomic status and survival of gastric cancer patientsV Fontana, A Decensi, M A Orengo, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 3, 1999
Prevention of breast cancer: focus on chemopreventionA Costa, B Bonanni, L Manetti, et al.International Journal of Cancer|August 5, 2000
Time course of fenretinide-induced modulation of circulating insulin-like growth factor (IGF)-i, IGF-II and IGFBP-3 in a bladder cancer chemoprevention trialR Torrisi, M Mezzetti, H Johansson, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1997
Long-term effects of fenretinide on retinal functionA Decensi, V Fontana, M Fioretto, et al.Pageof 21